Agreed. I think the short term outlook looks a little concerning though. Unless specialty grows even more rapidly than it has (and with Tolsura this is a possibility). Looks like key generic brands will lose share with competition - the main offset we've been waiting for is Nuvaring which is now more than 12 months away. I'm a huge believer in the long term of this company. But I don't see the price doing much in the short term. Hope I am wrong, as I was well wrong with my previous predictions too! Good luck to all holders.
Keep an eye at 86-87, page-5
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.48 |
Change
0.300(7.18%) |
Mkt cap ! $393.8M | |||
| Open | High | Low | Value | Volume |
| $4.22 | $4.50 | $4.18 | $1.134M | 259.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 708 | $4.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.50 | 1182 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| MYX (ASX) Chart |
